ID: ALA4447664

Max Phase: Preclinical

Molecular Formula: C21H23N3O2

Molecular Weight: 349.43

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  N[C@@H]1C(=O)N2c3ccccc3[C@@]34CCN5CC6=CCO[C@@H]1[C@@H]([C@H]23)[C@H]6C[C@H]54

Standard InChI:  InChI=1S/C21H23N3O2/c22-17-18-16-12-9-15-21(6-7-23(15)10-11(12)5-8-26-18)13-3-1-2-4-14(13)24(19(16)21)20(17)25/h1-5,12,15-19H,6-10,22H2/t12-,15-,16-,17-,18+,19-,21+/m0/s1

Standard InChI Key:  XHGQHKSZUGARHU-VJTNSULXSA-N

Associated Targets(Human)

Glycine receptor (alpha-1/beta) 119 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Glycine receptor subunit alpha-1 392 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 349.43Molecular Weight (Monoisotopic): 349.1790AlogP: 1.03#Rotatable Bonds: 0
Polar Surface Area: 58.80Molecular Species: BASEHBA: 4HBD: 1
#RO5 Violations: 0HBA (Lipinski): 5HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: 13.89CX Basic pKa: 9.28CX LogP: 0.10CX LogD: -2.19
Aromatic Rings: 1Heavy Atoms: 26QED Weighted: 0.71Np Likeness Score: 2.63

References

1. Zlotos DP, Mohsen AMY, Mandour YM, Marzouk MA, Breitinger U, Villmann C, Breitinger HG, Sotriffer C, Jensen AA, Holzgrabe U..  (2019)  11-Aminostrychnine and N-(Strychnine-11-yl)propionamide: Synthesis, Configuration, and Pharmacological Evaluation at Glycine Receptors.,  82  (8): [PMID:31385511] [10.1021/acs.jnatprod.9b00180]

Source